Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

AstraZeneca PLC ADR (AZN)

NASDAQ
Symbol
Exchange
Currency
AZNNASDAQUSD
AZNlBATS EuropeGBP
AZNsBATS EuropeSEK
AZNCFOTC MarketsUSD
3LAZLondonGBP
AZNLondonGBP
3SAZLondonGBP
AZNNMexicoMXN
AZNNBIVAMXN
AZNStockholmSEK
AZNXetraEUR
AZNTradeGateEUR
AZNFrankfurtEUR
AZNPyFrankfurtEUR
AZNBuenos AiresARS
AZNAViennaEUR
Currency in USD
Disclaimer
68.36
-0.17(-0.25%)
Closed
Pre Market
68.11-0.25(-0.37%)

AZN Comments

Forget about Covid-19 vaccine, Now AZN will provide Tagrisso drug to treat lung cancer for more than 50 countries, including US and China, and of cause India.
AstraZeneca PLC said Friday that its Tagrisso drug has been approved in the European Union to treat early stages of lung cancer.The pharmaceutical company said the results from the Adaura Phase 3 trial showed that Tagrisso reduced the risk of disease recurrence or death by 80%.Tagrisso has now been approved in more than 50 countries, including the U.S. and China, AstraZeneca said.
down the drain you mean with the astra zenica poison, pfizer Will take over all sales CDC is about to ban astra zenica
up up & away! the dumpers will not be able to hold on. I will buy and wait $65.
No country in Europe is using this nonsense anymore. The pumpers will not be able to hold on. I will sell and wait 47.
who cares about the death of Lisa Shaw, AZN will continue to go up.
AZ killed Lisa Shaw, ******
Experts who shorted the stock are suffering. See you guys when they completed the acquisition.
I agree. Just want to get out at even and never buy this again.
astra zenica is nothing more than a leathel injection
The giant is growing, AstraZeneca’s $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulator
LOL, rumors are not truth. Nobody knows what the truth is. When EU heard blood clots, they banned AZN vaccine. Now they accused AstraZeneca of failing to respect its contract.
Look at the big trading volume, hmmmm
That's right, keep going down, fat cow
Be proud, but there are others who are proud of theirs. No problem ... success
The stock price will exceed $60 in 2-3 weeks.
We are proud to have produced a vaccine for the world, which is playing a leading role in the global fight against the pandemic, with more than 400 million doses now supplied by AstraZeneca and sub-licensees to 165 countries.
400 million doses now supplied for past 2 months, the company is really on track to deliver 200 million doses each month.
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
And to whom will he deliver them? This pump today will not work very well.
LOL, rumor. Earnings report said that The company made $275 million from 68 million doses, and the company is on track to deliver 200 million doses each month.
sell all your stock at once
stockdump in the making
billions of euro's in damages in the making from EU for not deliver in time.
coming soon fast train to dungeon
it is time to jump high. big news is coming.....please tie your seat belt ladies and gentlemen.🚀🚀🚀
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.